Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest of Niagen Bioscience, Inc. from 28 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
Niagen Bioscience, Inc. quarterly and annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD history and change rate from 28 Dec 2013 to 31 Dec 2025.
  • Niagen Bioscience, Inc. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending 31 Dec 2025 was $4,424,000, a 41% decline year-over-year.
  • Niagen Bioscience, Inc. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending 31 Dec 2025 was $18,192,000, a 105% increase year-over-year.
  • Niagen Bioscience, Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2025 was $18,192,000, a 105% increase from 2024.
  • Niagen Bioscience, Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2024 was $8,855,000.
  • Niagen Bioscience, Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was $4,938,000.
Source SEC data
View on sec.gov
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Change (%)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Change (%)

Niagen Bioscience, Inc. Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $18,192,000 $4,424,000 -$3,060,000 -41% 01 Oct 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
Q3 2025 $21,252,000 $4,800,000 +$2,922,000 +156% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $18,330,000 $3,737,000 +$3,752,000 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $14,578,000 $5,231,000 +$5,723,000 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $8,855,000 $7,484,000 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
Q3 2024 $1,878,000 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $15,000 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $492,000 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q2 2017 $8,424,085 $2,764,124 -$2,677,370 -3086% 02 Apr 2017 01 Jul 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 $5,746,715 $1,928,755 -$2,195,120 -824% 01 Jan 2017 01 Apr 2017 10-Q 11 May 2017 2017 Q1
Q4 2016 $3,551,595 $2,773,663 -$1,485,074 -115% 02 Oct 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 $2,066,521 $957,543 -$953,827 03 Jul 2016 01 Oct 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 $1,112,694 $86,754 +$228,438 +72% 03 Apr 2016 02 Jul 2016 10-Q 10 Aug 2017 2017 Q2
Q1 2016 $1,341,132 $266,365 +$1,291,880 03 Jan 2016 02 Apr 2016 10-Q 11 May 2017 2017 Q1
Q4 2015 $2,633,012 $1,288,589 04 Oct 2015 02 Jan 2016 10-K 15 Mar 2018 2017 FY
Q3 2015 $3,716* 05 Jul 2015 03 Oct 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $315,192 05 Apr 2015 04 Jul 2015 10-Q 11 Aug 2016 2016 Q2
Q1 2015 $1,025,515 03 Jan 2015 04 Apr 2015 10-Q 12 May 2016 2016 Q1

Niagen Bioscience, Inc. Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $18,192,000 +$9,337,000 +105% 01 Jan 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
2024 $8,855,000 +$13,793,000 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
2023 $4,938,000 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2017 $16,529,746 -$12,978,151 -365% 01 Jan 2017 30 Dec 2017 10-K 15 Mar 2018 2017 FY
2016 $3,551,595 -$918,583 -35% 03 Jan 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
2015 $2,633,012 +$2,755,173 +51% 04 Jan 2015 02 Jan 2016 10-K 15 Mar 2018 2017 FY
2014 $5,388,185 -$968,660 -22% 29 Dec 2013 03 Jan 2015 10-K 16 Mar 2017 2016 FY
2013 $4,419,525 30 Dec 2012 28 Dec 2013 10-K 17 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.